Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Metadata
Title
Special Section on the MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis - 2019 Update
Guest Editor: Sharon Elad, DMD MSc
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04929-4

Other articles of this Issue 10/2019

Supportive Care in Cancer 10/2019 Go to the issue

Original Article

Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy

Review Article

Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature

Editorial

The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles

Original Article

A feasibility study examining the impact of yoga on psychosocial health and symptoms in pediatric outpatients receiving chemotherapy

Review Article

The effects of Tai Chi on quality of life of cancer survivors: a systematic review and meta-analysis

Original Article

Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits